Dengue Vaccine Candidate Appears Effective In Phase 3 Trial Except Against One Type In People With No Prior Exposure

Reuters (11/6, Steenhuysen) reports Takeda Pharmaceutical’s experimental dengue vaccine appeared to be “highly effective” in a phase 3 trial; however, the vaccine candidate “failed to protect against one type of the virus in people with no prior exposure...